In patients with autoimmune PAP (aPAP), comprising 90 % of all PAP cases, GM-CSF autoantibody (GMAb) is excessively produced [2, 7, 8]. The gene discussed is CSF2; the disease is autoimmune pulmonary alveolar proteinosis.